Weight loss drugs can halve heart patients’ risk of early death, study finds
The Guardianarrow_outwardSTOXX 600 ends higher on defence boost; Novo Nordisk jumps after Wegovy data
Reutersarrow_outwardWeight loss jabs could keep heart failure patients out of hospital
The Independentarrow_outwardWegovy surpasses zepbound in cardiovascular disease treatment effectiveness - CHOSUNBIZ - Chosun Biz
Chosun Bizarrow_outwardWegovy Outperforms Tirzepatide in Reducing Major Adverse Cardiovascular Events - Drug Topics
Drug Topicsarrow_outwardVideo New study on Wegovy and heart disease - ABC News
ABC Newsarrow_outwardWegovy cuts heart attack, stroke and death risk in CVD patients - Longevity.Technology
Longevity.Technologyarrow_outwardNovo's Wegovy tops Lilly's Zepbound at curbing cardio risks in real-world study - Fierce Pharma
Fierce Pharmaarrow_outwardWegovy Reduces Cardiovascular Risk by 57 Percent Compared to Tirzepatide in Recent Study - geneonline.com
Geneonline.comarrow_outwardWhat's Going On With Novo Nordisk Stock Tuesday? - Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY) - Benzinga
Benzingaarrow_outwardNovo’s Wegovy Cuts Cardio Risk by 57% Versus Tirzepatide - BioSpace
BioSpacearrow_outwardNew 4-in-1 weight loss drug 'combines Mounjaro and Ozempic effects' and 'melts fat' quicker than both - LADbible
LADbiblearrow_outwardCould GLP-1 weight-loss medications like Ozempic become the 'everything drug'? - Fox News
Fox Newsarrow_outwardWegovy’s Cardiovascular Edge: A Strategic Catalyst for Novo Nordisk’s Market Leadership - AInvest
AInvestarrow_outwardNovo Nordisk Stock Jumps and Eli Lilly Falls on Positive Wegovy Data - TipRanks
TipRanksarrow_outwardNovo’s Wegovy shows heart benefit but Korean doctors see Lilly’s Mounjaro as stronger on weight loss - koreabiomed.com
Koreabiomed.comarrow_outwardMounjaro users switching to Wegovy amid price hikes urged to take this step first - The Mirror
The Mirrorarrow_outwardWegovy Achieves 16% Weight Loss in East Asian Study - 조선일보
조선일보arrow_outwardSTOXX 600 ends higher on defence boost; Novo Nordisk jumps after Wegovy data By Reuters - Investing.com
Investing.comarrow_outwardThe Expanding MASH Market: How Rezdiffra, Wegovy Might Coexist - insights.citeline.com
Insights.citeline.comarrow_outwardESC25: Novo's Wegovy slashes CV risk by 57% over Lilly's Zepbound in real-world study - FirstWord Pharma
FirstWord Pharmaarrow_outwardWegovy trial result gives boost to Novo Nordisk amid U.S. market woes - MSN
MSNarrow_outwardWegovy trial result gives boost to Novo Nordisk amid U.S. market woes - CNBC
CNBCarrow_outwardESC: Real-world study gives Wegovy edge over Lilly rival - pharmaphorum
Pharmaphorumarrow_outwardESC 2025: Novo Nordisk’s Wegovy superior to Zepbound in reducing CV events - Pharmaceutical Technology
Pharmaceutical Technologyarrow_outwardNovo Nordisk says Wegovy cuts heart risk by 57% compared with Eli Lilly’s obesity drug | Company Business News - Mint
Mintarrow_outwardNovo’s Wegovy Beats Lilly’s Zepbound for Heart Health, Study Finds. What It Means for Stocks. - Barron's
Barron'sarrow_outwardNovo Nordisk’s Wegovy cuts heart attack, stroke or death risk by 57% vs tirzepatide - The Pharma Letter
The Pharma Letterarrow_outwardSTOXX 600 ends higher on defence boost; Novo Nordisk jumps after Wegovy data - MarketScreener
MarketScreenerarrow_outwardNovo Nordisk Shines With Wegovy’s Heart Health Results - Finimize
Finimizearrow_outwardEuropean stocks rise as Novo Nordisk lifts healthcare on Wegovy data - The Economic Times
The Economic Timesarrow_outwardEuropean stocks rise as Novo Nordisk lifts healthcare on Wegovy data - TradingView
TradingViewarrow_outwardNovo Nordisk Says Wegovy Cuts Heart Risk by 57% Compared With Eli Lilly’s Obesity Drug - The Wall Street Journal
The Wall Street Journalarrow_outwardBefore you switch from Mounjaro to Wegovy, read about my mistake - Daily Mail
Daily Mailarrow_outwardWegovy injection reduces heart attacks and stroke risks - The Jerusalem Post
The Jerusalem Postarrow_outwardNovo's Wegovy beats Lilly’s Zepbound in real-world study for heart diseases - Seeking Alpha
Seeking Alphaarrow_outwardNovo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular diseas - Yahoo Finance
Yahoo Financearrow_outwardNovo Nordisk's Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease - PR Newswire
PR Newswirearrow_outwardWeight-loss injections: How do drugs like Wegovy and Mounjaro work? - BBC
BBCarrow_outwardOzempic to Mounjaro - what are the weight loss injections and what were they designed to do? - Sky News
Sky Newsarrow_outwardNovo Nordisk links to telehealth providers for patients seeking Wegovy | STAT - statnews.com
Statnews.comarrow_outwardWegovy user left 'so happy' by unexpected symptom one week in to injections - UNILAD
UNILADarrow_outwardWegovy Is Now the Second FDA-Approved Treatment for MASH Fibrosis - Verywell Health
Verywell Healtharrow_outwardA Common Weight Loss Drug Can Treat Severe Liver Disease, F.D.A. Says - The New York Times
The New York Timesarrow_outwardNovo Advances After US Clears Wegovy for Liver Disease - Bloomberg.com
Bloomberg.comarrow_outwardQuit Ozempic or Wegovy? Here’s How Fast the Pounds Can Come Back - SciTechDaily
SciTechDailyarrow_outwardWegovy maker Novo Nordisk warns of layoffs as competition grows - Al Jazeera
Al Jazeeraarrow_outwardDrugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding - NPR
NPRarrow_outwardWegovy nutrition: What to eat and what to avoid - MedicalNewsToday
MedicalNewsTodayarrow_outwardNovo Nordisk ends Hims & Hers tie-up over copycat Wegovy drugs - Financial Times
Financial Timesarrow_outwardNew weight-loss drug is ‘better than Wegovy’ — and comes in a pill - The Times
The Timesarrow_outwardWegovy and Mounjaro might affect how well your contraceptives work – here’s why - The Conversation
The Conversationarrow_outwardWeight loss drugs: the essentials for non-specialists - Royal College of Nursing
Royal College of Nursingarrow_outwardZepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine - Eli Lilly and Company
Eli Lilly and Companyarrow_outwardDrugs like Wegovy can be effective at treating fatty liver disease - New Scientist
New Scientistarrow_outwardFirst randomised trial indicates Wegovy effective for treating alcohol-use disorder - Pulse Today
Pulse Todayarrow_outward
Wegovy close
- 2025-09-03 15:20 event
- 56 sourceslanguage
- 200+ ads_click
- 1 week ago schedule